Geduld E E - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 18 filers reported holding IMMUNE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geduld E E ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$5,000
-28.6%
25,0000.0%0.00%
-57.1%
Q3 2016$7,000
-30.0%
25,0000.0%0.01%
-46.2%
Q2 2016$10,000
-9.1%
25,0000.0%0.01%
-13.3%
Q1 2016$11,000
-57.7%
25,000
-28.6%
0.02%
-6.2%
Q4 2015$26,000
-36.6%
35,0000.0%0.02%
-57.9%
Q3 2015$41,000
-39.7%
35,0000.0%0.04%
-9.5%
Q2 2015$68,000
+7.9%
35,0000.0%0.04%0.0%
Q1 2015$63,000
-4.5%
35,0000.0%0.04%
+16.7%
Q4 2014$66,000
-50.7%
35,000
-12.5%
0.04%
-62.1%
Q3 2014$134,00040,0000.10%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Geduld E E 35,000$63,0000.04%
Ifrah Financial Services, Inc. 21,956$39,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$23,0000.01%
Pine River Capital Management L.P. 250,000$260,0000.00%
Virtu KCG Holdings LLC 55,599$100,0000.00%
A.R.T. Advisors, LLC 10,408$18,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
CITIGROUP INC 255$00.00%
GOLDMAN SACHS GROUP INC 33,616$60,0000.00%
MORGAN STANLEY 40$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders